DEA extends telemedicine prescribing flexibilities through 2026, allowing remote controlled substance prescriptions without in-person visits.

The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...

The extension allows providers to continue remotely prescribing Schedule II–V controlled substances under specific conditions to prevent a disruptive "telemedicine cliff." ...

For elements 7 and 8 above, the NPRM describes how the DEA may adopt one or both proposals. The appointment of a lead for the DEA by President-elect Donald Trump remains pending, leaving uncertainty ...

Practitioners who want to prescribe controlled substances via telehealth to patients in Florida must meet the requirements of both federal and state law. The federal Drug Enforcement Administration ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The flexibility for remote prescribing of controlled ...

In the letter, the telehealth advocates pushed the DEA to work directly with experts and other stakeholders on how to craft policy on virtual prescribing — an increasingly urgent concern given the ...

The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to finish permanent policies, the agencies said. During the COVID-19 pandemic ...